secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acumen Pharmaceuticals, Inc. (ABOS)
CIK:        0001576885
Form:       8-K
Filed at:   2022-06-21T23:59:59+00:00
Accession:  0001193125-22-177636
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Acumen shareholders elect all director nominees and ratify E&Y as auditor at annual meeting
--------------------------------------------------------------------------------

- All three Class I director nominees elected: Kimberlee C. Drapkin, Jeffrey Ives (Ph.D.), Sean Stalfort; broker non-votes of 5,658,008.
- Ratification of Ernst & Young as independent auditor received 34,702,393.73 votes for, 761.18 against, 165 abstentions.
- Approximately 85.69% of outstanding shares (34,703,319.92 of 40,496,512) were present or represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576885/000119312522177636/0001193125-22-177636-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576885/000119312522177636/d371573d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-177636

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer